» Articles » PMID: 27498170

Carcinogenesis Explained Within the Context of a Theory of Organisms

Overview
Date 2016 Aug 8
PMID 27498170
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

For a century, the somatic mutation theory (SMT) has been the prevalent theory to explain carcinogenesis. According to the SMT, cancer is a cellular problem, and thus, the level of organization where it should be studied is the cellular level. Additionally, the SMT proposes that cancer is a problem of the control of cell proliferation and assumes that proliferative quiescence is the default state of cells in metazoa. In 1999, a competing theory, the tissue organization field theory (TOFT), was proposed. In contraposition to the SMT, the TOFT posits that cancer is a tissue-based disease whereby carcinogens (directly) and mutations in the germ-line (indirectly) alter the normal interactions between the diverse components of an organ, such as the stroma and its adjacent epithelium. The TOFT explicitly acknowledges that the default state of all cells is proliferation with variation and motility. When taking into consideration the principle of organization, we posit that carcinogenesis can be explained as a relational problem whereby release of the constraints created by cell interactions and the physical forces generated by cellular agency lead cells within a tissue to regain their default state of proliferation with variation and motility. Within this perspective, what matters both in morphogenesis and carcinogenesis is not only molecules, but also biophysical forces generated by cells and tissues. Herein, we describe how the principles for a theory of organisms apply to the TOFT and thus to the study of carcinogenesis.

Citing Articles

Bioelectricity is a universal multifaced signaling cue in living organisms.

Zhang G, Levin M Mol Biol Cell. 2025; 36(2):pe2.

PMID: 39873662 PMC: 11809311. DOI: 10.1091/mbc.E23-08-0312.


The systemic evolutionary theory of the origin of cancer (SETOC): an update.

Mazzocca A, Ferraro G, Misciagna G Mol Med. 2025; 31(1):12.

PMID: 39806272 PMC: 11730465. DOI: 10.1186/s10020-025-01069-w.


The theragnostic advances of exosomes in managing leukaemia.

Ghosh S, Dey A, Chakrabarti A, Bhuniya T, Indu N, Hait A J Cell Mol Med. 2024; 28(23):e70052.

PMID: 39659020 PMC: 11632122. DOI: 10.1111/jcmm.70052.


UCapsNet: A Two-Stage Deep Learning Model Using U-Net and Capsule Network for Breast Cancer Segmentation and Classification in Ultrasound Imaging.

Madhu G, Meher Bonasi A, Kautish S, Almazyad A, Mohamed A, Werner F Cancers (Basel). 2024; 16(22).

PMID: 39594732 PMC: 11592068. DOI: 10.3390/cancers16223777.


Natural product-inspired [3 + 2] cycloaddition-based spirooxindoles as dual anticancer agents: synthesis, characterization, and biological evaluation by and methods.

Nivetha N, Don Hamid J, Simha N A, Devegowda D, Ramu R, Velmathi S RSC Med Chem. 2024; .

PMID: 39416974 PMC: 11474387. DOI: 10.1039/d4md00634h.


References
1.
Soto A, Sonnenschein C . The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory. Bioessays. 2011; 33(5):332-40. PMC: 3933226. DOI: 10.1002/bies.201100025. View

2.
McCullough K, Coleman W, Smith G, Grisham J . Age-dependent induction of hepatic tumor regression by the tissue microenvironment after transplantation of neoplastically transformed rat liver epithelial cells into the liver. Cancer Res. 1997; 57(9):1807-13. View

3.
Jordan V, Lewis-Wambi J, Patel R, Kim H, Ariazi E . New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis. Breast. 2009; 18 Suppl 3:S10-7. PMC: 2867601. DOI: 10.1016/S0960-9776(09)70266-8. View

4.
Barclay W, Woodruff R, Craig Hall M, Cramer S . A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology. 2004; 146(1):13-8. PMC: 3033046. DOI: 10.1210/en.2004-1123. View

5.
Sonnenschein C, Soto A . The aging of the 2000 and 2011 Hallmarks of Cancer reviews: a critique. J Biosci. 2013; 38(3):651-63. PMC: 3882065. DOI: 10.1007/s12038-013-9335-6. View